What does your DNA say about you?
We offer comprehensive evaluations with many Genetic testing options such as
Myriad Genetics (Hereditary Cancer): Approximately five to 10 percent of all cancers are hereditary. Patients with a hereditary cancer syndrome are at a significant risk for developing an initial cancer and a second primary cancer. Hereditary cancer is more prevalent than might be expected. In fact, there are very likely patients in your practice who carry the genetic mutations responsible for increased cancer risk. Identifying these patients through appropriate testing can potentially lead to improved treatment options, more appropriate plans for risk management, and, ultimately, better outcomes.
PgX : Each person has a unique Genetic structure. Prescription medication can often create unwanted, and at times deadly side effects. If you are experiencing side effects related to a drug regimen change , or prescription addition, than a PGX test may unlock the mystery. This report explains what a PGX test is, how it is interpreted, and the benefits for those suffering adverse prescription effects.
Cologuard: As the only FDA-approved test based on stool DNA science, Cologuard finds 92% of colon cancers and 69% of the highest-risk precancers with 87% specificity. Cologuard is not for everyone. Cologuard is not a replacement for diagnostic or surveillance colonoscopy in patients at high risk for colorectal cancer. Both false positives and false negatives do occur. In a clinical study of Cologuard, 13% of people without cancer or precancer tested positive. Any positive should be followed by a diagnostic colonoscopy. A negative Cologuard test result does not guarantee absence of cancer or advanced adenoma. Following a negative result, patients should continue participating in a screening program at an interval and with a method appropriate for the individual patient.